Acadia Pharmaceuticals (ACAD) Financials: Revenue & Earnings

ACAD price $20.32 +0.15 +0.74%

Ticker
ACAD
Price
$20.32
Change
+0.15 +0.74%
Market cap ?
$3.50B
P/E ?
8.77
Forward P/E ?
32.60
Dividend yield ?
0.00%
Beta ?
0.89
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
57
Value
56
Quality
52
Growth
62

Stocklytics score rationale: value 56, quality 52, growth 62.

Financials

2016201720182019202020212022202320242025
173310001249010002238070003390760004417550004841450005172350007264370009577970001071505000

Acadia Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions…

Fair value

ACAD fair value $25.38. Price $20.32. Price is 20% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 95% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ACAD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.20—332.58M
2026-08-040.180.07307.96M296.55M
2026-05-060.020.04268.10M280.25M
2026-02-251.600.14283.99M292.79M
2025-11-050.420.14278.63M276.54M
2025-08-060.160.14264.57M262.00M
2025-05-070.110.10244.32M238.97M
2025-02-260.860.19259.60M255.61M
2024-11-060.200.14250.40M282.92M
2024-08-060.200.18241.96M235.42M
2024-05-080.100.05205.83M208.29M
2024-02-270.280.30231.04M223.78M
2023-11-02-0.40-0.43211.70M224.38M
2023-08-020.01-0.12165.24M157.85M
2023-05-08-0.27-0.21118.46M120.08M
2023-02-27-0.26-0.25136.49M134.23M
2022-11-02-0.17-0.18130.71M138.76M
2022-08-08-0.21-0.25134.56M130.41M
2022-05-04-0.70-0.49115.47M121.91M
2022-02-28-0.27-0.24130.76M135.39M
2021-11-08-0.09-0.27131.61M135.38M
2021-08-04-0.27-0.30115.22M115.22M
2021-05-05-0.42-0.53106.55M110.22M
2021-02-24-0.42-0.48121.01M123.26M
2020-11-04-0.54-0.38120.58M84.85M
2020-08-05-0.27-0.44110.10M179.43M
2020-05-07-0.57-0.4690.07M75.85M
2020-02-26-0.34-0.3798.33M104.11M
2019-10-30-0.29-0.4194.59M130.46M
2019-07-31-0.38-0.4683.20M98.53M
2019-05-01-0.59-0.5462.96M55.49M
2019-02-26-0.50-0.5559.57M65.53M
2018-11-06-0.50-0.5858.30M67.63M
2018-08-08-0.51-0.4557.06M50.35M
2018-05-04-0.44-0.5648.87M61.09M
2018-02-27-0.55-0.5843.56M45.94M
2017-11-07-0.53-0.6335.58M41.62M
2017-08-08-0.55-0.7130.48M39.89M
2017-05-09-0.72-0.7315.29M15.50M
2017-02-28-0.65-0.6511.96M11.96M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-06Schneyer Mark C.Buy14.29K$17.84254.97K
2026-08-06Schneyer Mark C.Sell5.00K$29.00145.00K
2026-08-06Schneyer Mark C.Sell9.29K$29.34272.60K
2026-08-06Schneyer Mark C.Sell14.29K$17.84254.97K
2026-08-05Schneyer Mark C.Sell5.85K$17.84104.35K
2026-08-05Schneyer Mark C.Buy5.85K$17.84104.35K
2026-08-05Schneyer Mark C.Sell5.85K$29.00169.64K
2026-07-30Thompson Elizabeth H.Z.Sell16.51K$26.13431.35K
2026-07-30Thompson Elizabeth H.Z.Sell50$26.171.31K
2026-07-29Thompson Elizabeth H.Z.Buy32.27K——
2026-07-29Thompson Elizabeth H.Z.Sell32.27K——
2026-06-26Kihara JamesSell11.42K$26.08297.91K
2026-05-29BAKER BROS. ADVISORS LPBuy18.62K——
2026-05-29BAKER BROS. ADVISORS LPBuy18.62K——
2026-05-29BAKER BROS. ADVISORS LPBuy32.01K$21.66693.29K
2026-05-29HARRIGAN EDMUNDBuy8.11K——
2026-05-29HARRIGAN EDMUNDBuy16.00K$21.66346.65K
2026-05-29HARRIGAN EDMUNDBuy9.31K——
2026-05-29HARRIGAN EDMUNDSell8.11K——
2026-05-29Ndu AdoraBuy8.11K——
2026-05-29Ndu AdoraBuy16.00K$21.66346.65K
2026-05-29Ndu AdoraBuy9.31K——
2026-05-29Ndu AdoraSell8.11K——
2026-05-29Brege LauraBuy8.11K——
2026-05-29Brege LauraBuy16.00K$21.66346.65K
2026-05-29Brege LauraBuy9.31K——
2026-05-29Brege LauraSell8.11K——
2026-05-29Poole JonathanBuy16.00K$21.66346.65K
2026-05-29Poole JonathanBuy9.31K——
2026-05-29Poole JonathanBuy2.01K——
2026-05-29Poole JonathanSell2.01K——
2026-05-29GAROFALO ELIZABETH A.Buy8.11K——
2026-05-29GAROFALO ELIZABETH A.Buy16.00K$21.66346.65K
2026-05-29GAROFALO ELIZABETH A.Buy9.31K——
2026-05-29GAROFALO ELIZABETH A.Sell8.11K——
2026-05-29Daly James MBuy16.00K$21.66346.65K
2026-05-29Daly James MBuy8.11K——
2026-05-29Daly James MBuy9.31K——
2026-05-29Daly James MSell8.11K——
2026-05-26Kihara JamesSell5.40K$21.18114.39K
2026-05-04Kihara JamesSell1.33K$21.7929.02K
2026-05-04Schneyer Mark C.Sell3.51K$21.7976.40K
2026-05-01Kihara JamesBuy2.60K——
2026-05-01Kihara JamesSell2.60K——
2026-05-01Schneyer Mark C.Buy6.82K——
2026-05-01Schneyer Mark C.Sell6.82K——
2026-04-07Schneyer Mark C.Sell2.71K$22.2060.14K
2026-04-07Kihara JamesSell1.03K$22.2022.87K
2026-04-05Schneyer Mark C.Buy5.28K——
2026-04-05Schneyer Mark C.Sell5.28K——
2026-04-05Kihara JamesBuy2.01K——
2026-04-05Kihara JamesSell2.01K——
2026-03-26Kihara JamesSell1.10K$21.6523.75K
2026-03-26Kihara JamesSell12$21.73261
2026-03-26Schneyer Mark C.Sell3.17K$21.6568.65K
2026-03-26Schneyer Mark C.Sell37$21.72804
2026-03-25Owen Adams CatherineSell11.64K$21.47249.93K
2026-03-25Rhodes Jennifer JSell3.84K$21.4782.53K
2026-03-25Thompson Elizabeth H.Z.Sell3.44K$21.4773.75K
2026-03-25Kihara JamesBuy2.14K——
2026-03-25Kihara JamesSell833$21.4717.88K
2026-03-25Kihara JamesSell2.14K——
2026-03-25Schneyer Mark C.Buy6.18K——
2026-03-25Schneyer Mark C.Sell4.18K$21.4789.68K
2026-03-25Schneyer Mark C.Sell6.18K——
2026-03-24Owen Adams CatherineSell23.51K——
2026-03-24Owen Adams CatherineBuy23.51K——
2026-03-24Rhodes Jennifer JSell7.51K——
2026-03-24Thompson Elizabeth H.Z.Sell6.71K——
2026-03-24Rhodes Jennifer JBuy7.51K——
2026-03-24Thompson Elizabeth H.Z.Buy6.71K——
2026-03-24Kihara JamesBuy1.63K——
2026-03-24Kihara JamesSell1.63K——
2026-03-24Schneyer Mark C.Buy8.14K——
2026-03-24Schneyer Mark C.Sell8.14K——
2026-03-06Kihara JamesBuy21.77K$22.16482.33K
2026-03-06Kihara JamesBuy6.33K——
2026-03-06Rhodes Jennifer JBuy90.69K$22.162.01M
2026-03-06Rhodes Jennifer JBuy26.38K——
2026-03-06Schneyer Mark C.Buy90.69K$22.162.01M
2026-03-06Schneyer Mark C.Buy26.38K——
2026-03-06Garner ThomasBuy97.95K$22.162.17M
2026-03-06Garner ThomasBuy28.49K——
2026-03-06Thompson Elizabeth H.Z.Buy101.57K$22.162.25M
2026-03-06Thompson Elizabeth H.Z.Buy29.55K——
2026-03-06Owen Adams CatherineBuy263.00K$22.165.83M
2026-03-06Owen Adams CatherineBuy76.51K——
2026-03-03Poole JonathanBuy7.48K$22.50168.34K
2026-03-03Poole JonathanBuy4.22K——
2026-03-03Poole JonathanBuy3.56K$22.5080.21K
2026-03-03Poole JonathanBuy2.01K——
2026-03-03Poole JonathanOther0——
2026-02-09Rhodes Jennifer JSell6.95K$23.38162.49K
2026-02-06Rhodes Jennifer JBuy12.94K——
2026-02-06Rhodes Jennifer JSell12.94K——
2025-11-18Schneyer Mark C.Sell10.26K$23.69243.11K
2025-11-18Kihara JamesSell4.08K$23.6996.75K
2025-11-17Schneyer Mark C.Buy9.91K——
2025-11-17Schneyer Mark C.Buy9.91K——
2025-11-17Schneyer Mark C.Sell9.91K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 365, holders +7 vs prior quarter. Ownership 99.01%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP42.91M16.21K+0.04%1.09B
BLACKROCK, INC.22.52M964.25K+4.47%569.63M
STATE STREET CORP9.08M743.44K+8.92%229.63M
VANGUARD PORTFOLIO MANAGEMENT LLC8.84M166.81K+1.92%223.61M
RTW INVESTMENTS, LP7.14M00.00%180.76M
VANGUARD CAPITAL MANAGEMENT LLC5.76M102.35K+1.81%145.82M
DIMENSIONAL FUND ADVISORS LP3.69M539.83K+17.11%93.48M
GEODE CAPITAL MANAGEMENT, LLC3.36M-106.56K-3.08%84.98M
PALO ALTO INVESTORS LP2.86M-8.60K-0.30%72.46M
GOLDMAN SACHS GROUP INC2.58M1.02M+65.63%65.28M
QUBE RESEARCH & TECHNOLOGIES LTD2.45M1.50M+157.46%61.90M
POINT72 ASSET MANAGEMENT, L.P.2.43M-144.75K-5.61%61.56M
CITADEL ADVISORS LLC2.18M1.56M+250.40%55.21M
PICTET ASSET MANAGEMENT HOLDING SA1.98M-42.85K-2.11%50.15M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.97M399.95K+25.48%49.83M
MARSHALL WACE, LLP1.76M1.76MNew44.65M
D. E. SHAW & CO., INC.1.70M968.10K+132.65%42.96M
BRAIDWELL LP1.65M-824.80K-33.38%41.65M
NORGES BANK1.62M1.62MNew41.07M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.1.44M00.00%36.39M
NORTHERN TRUST CORP1.37M94.81K+7.45%34.60M
NUVEEN, LLC1.35M311.20K+30.01%34.11M
ARTISAN PARTNERS LIMITED PARTNERSHIP1.33M-6.68K-0.50%33.53M
BANK OF AMERICA CORP /DE/1.30M-253.38K-16.31%32.90M
RENAISSANCE TECHNOLOGIES LLC1.28M-441.60K-25.61%32.45M

Earnings and financials

Acadia Pharmaceuticals Inc. (ACAD) trades at $20.32, with a market cap of $3.50B and a trailing P/E of 8.77. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
173310001249010002238070003390760004417550004841450005172350007264370009577970001071505000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Acadia Pharmaceuticals (ACAD) Financials: Revenue & Earnings

ACAD$20.32+0.15 +0.74%

$3.50B

Market Cap

8.77

P/E

32.60

Forward P/E

57

Score

Price History